Viatris (VTRS) Research & Development (2020 - 2026)

Viatris' (VTRS) quarterly Research & Development came in at $248.6 million in Q1 2026, up 11.98% year-on-year from $222.0 million in Q1 2025, and up 138.67% quarter-over-quarter from -$642.9 million in Q4 2025.

Viatris (VTRS) Research & Development (2020 - 2026) Analysis & Trends

Viatris' Research & Development history runs 7 years deep, the most recent figure standing at $248.6 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 11.98% year-over-year to $248.6 million in Q1 2026; TTM through Mar 2026 was $74.9 million, a 48.02% increase from a year earlier, with the FY2025 full-year figure at $48.3 million, up 70.67% from the prior year.
  • Research & Development rose to $248.6 million in Q1 2026 per VTRS's latest filing, from -$642.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $662.2 million in Q4 2022 and bottomed at -$642.9 million in Q4 2025.
  • The 5-year median for Research & Development is $199.0 million (2024), against an average of $111.4 million.
  • Biggest YoY gain for Research & Development was 1900.98% in 2024; the steepest drop was 708.59% in 2024.
  • Year by year, Research & Development stood at $662.2 million in 2022, then sank by 85.76% to $94.3 million in 2023, then plunged by 708.59% to -$573.9 million in 2024, then fell by 12.02% to -$642.9 million in 2025, then jumped by 138.67% to $248.6 million in 2026.
  • Per Business Quant, the three latest VTRS Research & Development figures stand at $248.6 million (Q1 2026), -$642.9 million (Q4 2025), and $250.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 248.60 Mn
Dec 31, 2025 -642.90 Mn
Sep 30, 2025 250.40 Mn
Jun 30, 2025 218.80 Mn
Mar 31, 2025 222.00 Mn
Dec 31, 2024 -573.90 Mn
Sep 30, 2024 198.40 Mn
Jun 30, 2024 204.10 Mn
Mar 31, 2024 199.70 Mn
Dec 31, 2023 94.30 Mn
Sep 30, 2023 211.20 Mn
Jun 30, 2023 10.20 Mn
Dec 31, 2022 662.20 Mn
Sep 30, 2022 174.90 Mn
Jun 30, 2022 162.60 Mn
Mar 31, 2022 142.30 Mn
Dec 31, 2021 -413.80 Mn
Sep 30, 2021 152.10 Mn
Jun 30, 2021 147.70 Mn
Mar 31, 2021 184.10 Mn